HIV surveillance among injecting drug users
- 1 April 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15, S13-S22
- https://doi.org/10.1097/00002030-200104003-00003
Abstract
Injecting drug users (IDUs) should be considered a 'partially hidden population' at high risk for HIV infection. In almost all locations it should be possible to locate and conduct research with IDUs, but it will probably never be possible to enumerate or draw random samples from an IDU population. Surveillance research studies with IDUs should include risk behaviors, as surveillance of HIV infection only will not be sufficiently time sensitive, and be used to develop and refine HIV prevention programming for the population. Contacts with IDUs can be developed at multiple settings, including voluntary treatment programs, law enforcement settings, and through 'street outreach.' Each type of setting has different advantages, disadvantages and ethical concerns. HIV testing as part of surveillance also raises additional important ethical concerns. The primary risk behaviors that should be included in surveillance studies are 'sharing' of drug injection equipment, the potential for rapid partner change among risk partners, and sexual risk behavior. Additional important objectives for surveillance research include: (1) the size of the local IDU population, (2) patterns of drug use, (3) availability injection equipment, (4) participation in prevention activities, and (5) access to and use of anti-retroviral treatments. HIV incidence is an ultimate objective for surveillance research, but there are no currently available cost-efficient methods for studying HIV incidence, so estimation from indirect measurements is usually required.Keywords
This publication has 13 references indexed in Scilit:
- The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-makingAIDS, 1999
- Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain.American Journal of Epidemiology, 1998
- New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention PurposesJAMA, 1998
- Maximum impact of HIV prevention measures targeted at injecting drug usersAIDS, 1998
- Maintaining low HIV seroprevalence in populations of injecting drug usersPublished by American Medical Association (AMA) ,1995
- Topic-Focused Bibliography: Syringe Exchange: HIV Prevention, Key Findings, and Future DirectionsInternational Journal of the Addictions, 1995
- Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.American Journal of Public Health, 1994
- Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992Published by American Medical Association (AMA) ,1994
- Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug usersAIDS, 1993
- International epidemiology of HIV and AIDS among injecting drug usersAIDS, 1992